No difference was detected between LDLT and DDLT patients regarding graft survival at 1 (80% vs. 82%), at 3 (69% vs. 76%) and 5 years (65% vs. 76%) (p = 0.63), as well as patient survival at 1 (83% vs. 82%), 3 (72% vs. 77%) and 5 years (72% vs. 77%) (p = 0.93). The incidence of chronic kidney disease post-LT (10% vs. 6%; p = 0.4) was similar between both groups. Living donor living transplant results in identical long-term outcome when compared with deceased donor liver transplant in patients with HRS.
*Hepatorenal Sydrome = progressive kidney disease and failure due to cirrhosis of the liver.
Goldaracena, N., Marquez, M., Selzner, N., Spetzler, V., Cattral, M., Greig, P., Lilly, L., McGilvray, I., Levy, G., Ghanekar, A., Renner, E., Grant, D., & Selzner, M. (2014). Living vs. Deceased Donor Liver Transplantation Provides Comparable Recovery of Renal Function in Patients With Hepatorenal Syndrome: A Matched Case-Control Study American Journal of Transplantation DOI: 10.1111/ajt.12975